Novartis News

On Friday's close, Zalicus ended the day up an impressive 13.90%. But for no reason? Hardly.

According to GuruFocus list of 52-week lows , these Guru stocks have reached their 52-week lows.

Globally known as the world's largest drug maker, Pfizer leads a set of drug manufacturing companies in one of the most profitable industries.

It is a good thing for long-term investors when the market only looks at things a quarter or two at a time.

Breaking its previous mid-80 cent low, Zalicus has fallen, but on the heels of ZERO negative news.

Not so very long ago, Gold Bond Medicated Powder was an unimpressive product on the drugstore shelves of Rhode Island.

Wendy Phillips, a vet with the Arrowfield Veterinary Group, in Herefordshire, said both ewes and lambs will be at risk, especially if they are dirty, as weather conditions change.

According to GuruFocus' list of 52-week lows , these Guru stocks have reached their 52-week lows.

The event takes place on May 24th at the Three Counties Showground, Malvern. Farmers will also have the chance to win one of three Morris Cattle Crushes worth up to 1,850, on offer as prizes in the Novartis Animal Health Flypor competition.

Eli Lilly, along with other Big Pharma names such as GlaxoSmithKline and Novartis , has been colluding with Indian drug regulators to speed up approval procedures and put drugs on the Indian market that are not yet available or even legal in other countries.

The Street Beat commentary - The battle against breast cancer looks to be getting a few more weapons in its arsenal in the future.

Our annual list of 10 technologies that could change the world. This year: Light-field photography.

There's no question that Teva Pharmaceuticals rewarded long-term investors with years and years of growth as it became the world's largest generic drug manufacturer.

Executives from a handful of tech companies including iRobot, Amgen Corp. and Novartis, government leaders and faculty gathered at MIT Tuesday and Wednesday to address the future of manufacturing with a focus on workforce, challenges and innovation in manufacturing.

I have a headache. I get lots of headaches. Lots of people get lots of headaches I suppose, but mine are worse.

Former Novartis R&D exec Abbie Celniker is on her second biotech startup with Eleven Biotherapeutics, which has added $20 million to its Series A round.

Novartis has recently completed its acquisition of Fougera Pharmaceuticals through its own generic division Sandoz.

The U.K.'s publicly-funded National Health Service could save GBP84.5 million a year if it replaced a Novartis-marketed treatment for a common eye disease in elderly people with a cheaper, yet unapproved, rival drug from Roche Holding AG , a new study found.

An experimental drug by Novartis for the treatment of a rare endocrine disorder is working better than the standard of care in a late-stage clinical trial, the company said Monday.

With Jeremy Levin now CEO of Teva Pharmaceuticals , investors can expect more acquisitions for the biotech giant.